Global Blood Grouping Reagents Market, 2012 to 2023
Blood Grouping Reagents Market
Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks for the determination and identification of antibody type in patient’s and donors blood, in order to ensure the effective and safe transfusion of blood and to reduce the risks causing infections. Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.
Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lacking in the awareness, lack of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.
Global blood grouping reagent market is segmented on the basis of product, technique, test type, end user, and region.
Based on product, global blood grouping reagent market is segmented as
:
Consumables
Instruments
Based on technique, global blood grouping reagent market is segmented as
:
PCR-based and Microarray Technique
Assay-Based Techniques
Massively Parallel Sequencing Techniques
Other Techniques
Based on test type, global blood grouping reagent market is segmented as
:
Antibody Screening
HLA Typing
Cross-Matching Tests
ABO Blood Tests
Antigen Typing
Based on end-user, global blood grouping reagent market is segmented as
:
Hospitals
Blood Banks
Clinical Laboratories
Blood grouping reagents are the vital tools in diagnostic laboratories for blood group serology. Rise number of blood transfusion procedures is anticipated to pose great demand for the blood grouping reagents. In addition to this extended use of blood group reagents for the purpose of research is anticipated to propel the market growth of blood grouping reagents. As per the American Cancer Society, about 1.69 million people are going to be diagnosed with cancer in 2017. Which may have dire need of blood for the victims during chemotherapy treatment. Every day in U.S., approximately about 36,000 units of RBC, 7,000 units of platelets and 10,000 units of plasma are required and roughly 21 million blood components are transfused every year in U.S.
On the basis of geographical regions, blood grouping reagents market is segmented as
Latin America, North America, Asia Pacific, Europe, The Middle East and Africa. North America holds largest market share due to favourable reimbursement policies for surgeries, and rising incidence of the major blood disorders. Asia-Pacific market is anticipated to show significant growth rate due to rise in incidence and prevalence rate of chronic disorders in Asian countries.
Some of the players in the blood grouping reagents market are Grifols, S.A. (Spain), Bio-Rad Laboratories, Inc. (U.S.), Immucor, Inc. (U.S.), Quotient, Ltd. (U.S.), ), Novacyt Group (France), Ortho Clinical Diagnostics, Inc. (U.S.), BAG Healthcare GmbH (Germany), Day medical SA (Switzerland), Rapid Labs (U.K.), AXO Science (France). And DIAGAST (France)
In July 2017, Bio-Rad Laboratories, Inc., received U.S. FDA clearance for IH-1000 blood typing instrument to market in the US
In February 2017, Immucor, Inc., launched MIA FORA NGS FLEX HLA Typing Assay which provides comprehensive coverage up to 11 HLA genes
In November 2013, Grifols, acquired Novartis AG transfusion diagnostics unit to strengthen its Diagnostic Division and Bioscience Division
Report Outline:
The report provides granular level information about the market size, regional market share and forecast from 2017-2023
The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks for the determination and identification of antibody type in patient’s and donors blood, in order to ensure the effective and safe transfusion of blood and to reduce the risks causing infections. Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.
Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lacking in the awareness, lack of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.
Global blood grouping reagent market is segmented on the basis of product, technique, test type, end user, and region.
Based on product, global blood grouping reagent market is segmented as
:
Consumables
Instruments
Based on technique, global blood grouping reagent market is segmented as
:
PCR-based and Microarray Technique
Assay-Based Techniques
Massively Parallel Sequencing Techniques
Other Techniques
Based on test type, global blood grouping reagent market is segmented as
:
Antibody Screening
HLA Typing
Cross-Matching Tests
ABO Blood Tests
Antigen Typing
Based on end-user, global blood grouping reagent market is segmented as
:
Hospitals
Blood Banks
Clinical Laboratories
Blood grouping reagents are the vital tools in diagnostic laboratories for blood group serology. Rise number of blood transfusion procedures is anticipated to pose great demand for the blood grouping reagents. In addition to this extended use of blood group reagents for the purpose of research is anticipated to propel the market growth of blood grouping reagents. As per the American Cancer Society, about 1.69 million people are going to be diagnosed with cancer in 2017. Which may have dire need of blood for the victims during chemotherapy treatment. Every day in U.S., approximately about 36,000 units of RBC, 7,000 units of platelets and 10,000 units of plasma are required and roughly 21 million blood components are transfused every year in U.S.
On the basis of geographical regions, blood grouping reagents market is segmented as
Latin America, North America, Asia Pacific, Europe, The Middle East and Africa. North America holds largest market share due to favourable reimbursement policies for surgeries, and rising incidence of the major blood disorders. Asia-Pacific market is anticipated to show significant growth rate due to rise in incidence and prevalence rate of chronic disorders in Asian countries.
Some of the players in the blood grouping reagents market are Grifols, S.A. (Spain), Bio-Rad Laboratories, Inc. (U.S.), Immucor, Inc. (U.S.), Quotient, Ltd. (U.S.), ), Novacyt Group (France), Ortho Clinical Diagnostics, Inc. (U.S.), BAG Healthcare GmbH (Germany), Day medical SA (Switzerland), Rapid Labs (U.K.), AXO Science (France). And DIAGAST (France)
In July 2017, Bio-Rad Laboratories, Inc., received U.S. FDA clearance for IH-1000 blood typing instrument to market in the US
In February 2017, Immucor, Inc., launched MIA FORA NGS FLEX HLA Typing Assay which provides comprehensive coverage up to 11 HLA genes
In November 2013, Grifols, acquired Novartis AG transfusion diagnostics unit to strengthen its Diagnostic Division and Bioscience Division
Report Outline:
The report provides granular level information about the market size, regional market share and forecast from 2017-2023
The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL BLOOD GROUPING REAGENTS MARKET INTRODUCTION
2.1. Global Blood Grouping Reagents Market – Taxonomy
2.2. Global Blood Grouping Reagents Market –Definitions
2.2.1. Product
2.2.2. Technique
2.2.3. Test Type
2.2.4. End-User
3. GLOBAL BLOOD GROUPING REAGENTS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Blood Grouping Reagents Market Dynamic Factors - Impact Analysis
3.6. Global Blood Grouping Reagents Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Blood Grouping Reagents Market –Trends
4. GLOBAL BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Consumables
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY TECHNIQUE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. PCR-based and Microarray Technique
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Assay-Based Techniques
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Massively Parallel Sequencing Techniques
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Other Techniques
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Antibody Screening
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. HLA Typing
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cross-Matching Tests
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. ABO Blood Tests
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Antigen Typing
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY END - USE, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Blood Banks
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Clinical Laboratories
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. North America
9.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Region, 2017 – 2023
10. NORTH AMERICA BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. PCR-based and Microarray Technique
10.2.2. Assay-Based Techniques
10.2.3. Massively Parallel Sequencing Techniques
10.2.4. Other Techniques
10.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Antibody Screening
10.3.2. HLA Typing
10.3.3. Cross-Matching Tests
10.3.4. ABO Blood Tests
10.3.5. Antigen Typing
10.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Blood Banks
10.4.3. Clinical Laboratories
10.5. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
10.7. North America Blood Grouping Reagents Market Dynamics – Trends
11. EUROPE BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. PCR-based and Microarray Technique
11.2.2. Assay-Based Techniques
11.2.3. Massively Parallel Sequencing Techniques
11.2.4. Other Techniques
11.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Antibody Screening
11.3.2. HLA Typing
11.3.3. Cross-Matching Tests
11.3.4. ABO Blood Tests
11.3.5. Antigen Typing
11.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Blood Banks
11.4.3. Clinical Laboratories
11.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
11.7. Europe Blood Grouping Reagents Market Dynamics – Trends
12. ASIA-PACIFIC BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. PCR-based and Microarray Technique
12.2.2. Assay-Based Techniques
12.2.3. Massively Parallel Sequencing Techniques
12.2.4. Other Techniques
12.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Antibody Screening
12.3.2. HLA Typing
12.3.3. Cross-Matching Tests
12.3.4. ABO Blood Tests
12.3.5. Antigen Typing
12.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Blood Banks
12.4.3. Clinical Laboratories
12.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
12.7. Asia-Pacific Blood Grouping Reagents Market Dynamics – Trends
13. LATIN AMERICA BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. PCR-based and Microarray Technique
13.2.2. Assay-Based Techniques
13.2.3. Massively Parallel Sequencing Techniques
13.2.4. Other Techniques
13.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Antibody Screening
13.3.2. HLA Typing
13.3.3. Cross-Matching Tests
13.3.4. ABO Blood Tests
13.3.5. Antigen Typing
13.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals
13.4.2. Blood Banks
13.4.3. Clinical Laboratories
13.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
13.7. Latin America Blood Grouping Reagents Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
14.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. PCR-based and Microarray Technique
14.2.2. Assay-Based Techniques
14.2.3. Massively Parallel Sequencing Techniques
14.2.4. Other Techniques
14.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Antibody Screening
14.3.2. HLA Typing
14.3.3. Cross-Matching Tests
14.3.4. ABO Blood Tests
14.3.5. Antigen Typing
14.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospitals
14.4.2. Blood Banks
14.4.3. Clinical Laboratories
14.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
14.7. MEA Blood Grouping Reagents Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Grifols, S.A. (Spain)
15.2.2. Bio-Rad Laboratories, Inc. (U.S.)
15.2.3. Immucor, Inc. (U.S.)
15.2.4. Quotient, Ltd. (U.S.)
15.2.5. Novacyt Group (France)
15.2.6. Ortho Clinical Diagnostics, Inc. (U.S.)
15.2.7. BAG Healthcare GmbH (Germany)
15.2.8. Day medical SA (Switzerland)
15.2.9. Rapid Labs (U.K.)
15.2.10. AXO Science (France)
15.2.11. DIAGAST (France)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL BLOOD GROUPING REAGENTS MARKET INTRODUCTION
2.1. Global Blood Grouping Reagents Market – Taxonomy
2.2. Global Blood Grouping Reagents Market –Definitions
2.2.1. Product
2.2.2. Technique
2.2.3. Test Type
2.2.4. End-User
3. GLOBAL BLOOD GROUPING REAGENTS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Blood Grouping Reagents Market Dynamic Factors - Impact Analysis
3.6. Global Blood Grouping Reagents Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Blood Grouping Reagents Market –Trends
4. GLOBAL BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Consumables
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY TECHNIQUE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. PCR-based and Microarray Technique
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Assay-Based Techniques
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Massively Parallel Sequencing Techniques
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Other Techniques
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Antibody Screening
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. HLA Typing
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cross-Matching Tests
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. ABO Blood Tests
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Antigen Typing
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY END - USE, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Blood Banks
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Clinical Laboratories
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL BLOOD GROUPING REAGENTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. North America
9.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Region, 2017 – 2023
10. NORTH AMERICA BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. PCR-based and Microarray Technique
10.2.2. Assay-Based Techniques
10.2.3. Massively Parallel Sequencing Techniques
10.2.4. Other Techniques
10.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Antibody Screening
10.3.2. HLA Typing
10.3.3. Cross-Matching Tests
10.3.4. ABO Blood Tests
10.3.5. Antigen Typing
10.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Blood Banks
10.4.3. Clinical Laboratories
10.5. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
10.7. North America Blood Grouping Reagents Market Dynamics – Trends
11. EUROPE BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. PCR-based and Microarray Technique
11.2.2. Assay-Based Techniques
11.2.3. Massively Parallel Sequencing Techniques
11.2.4. Other Techniques
11.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Antibody Screening
11.3.2. HLA Typing
11.3.3. Cross-Matching Tests
11.3.4. ABO Blood Tests
11.3.5. Antigen Typing
11.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Blood Banks
11.4.3. Clinical Laboratories
11.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
11.7. Europe Blood Grouping Reagents Market Dynamics – Trends
12. ASIA-PACIFIC BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. PCR-based and Microarray Technique
12.2.2. Assay-Based Techniques
12.2.3. Massively Parallel Sequencing Techniques
12.2.4. Other Techniques
12.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Antibody Screening
12.3.2. HLA Typing
12.3.3. Cross-Matching Tests
12.3.4. ABO Blood Tests
12.3.5. Antigen Typing
12.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Blood Banks
12.4.3. Clinical Laboratories
12.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
12.7. Asia-Pacific Blood Grouping Reagents Market Dynamics – Trends
13. LATIN AMERICA BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. PCR-based and Microarray Technique
13.2.2. Assay-Based Techniques
13.2.3. Massively Parallel Sequencing Techniques
13.2.4. Other Techniques
13.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Antibody Screening
13.3.2. HLA Typing
13.3.3. Cross-Matching Tests
13.3.4. ABO Blood Tests
13.3.5. Antigen Typing
13.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals
13.4.2. Blood Banks
13.4.3. Clinical Laboratories
13.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
13.7. Latin America Blood Grouping Reagents Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA BLOOD GROUPING REAGENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
14.1. Product Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.2. Technique Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. PCR-based and Microarray Technique
14.2.2. Assay-Based Techniques
14.2.3. Massively Parallel Sequencing Techniques
14.2.4. Other Techniques
14.3. Test Type Analysis, 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Antibody Screening
14.3.2. HLA Typing
14.3.3. Cross-Matching Tests
14.3.4. ABO Blood Tests
14.3.5. Antigen Typing
14.4. End -Use Analysis, 2012- 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospitals
14.4.2. Blood Banks
14.4.3. Clinical Laboratories
14.5. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2017 – 2023
14.7. MEA Blood Grouping Reagents Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Grifols, S.A. (Spain)
15.2.2. Bio-Rad Laboratories, Inc. (U.S.)
15.2.3. Immucor, Inc. (U.S.)
15.2.4. Quotient, Ltd. (U.S.)
15.2.5. Novacyt Group (France)
15.2.6. Ortho Clinical Diagnostics, Inc. (U.S.)
15.2.7. BAG Healthcare GmbH (Germany)
15.2.8. Day medical SA (Switzerland)
15.2.9. Rapid Labs (U.K.)
15.2.10. AXO Science (France)
15.2.11. DIAGAST (France)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
